IMSN Neuromuscular Blocker Safety Interest Group (SIG)

The IMSN Neuromuscular Blocker Safety Interest Group is co-chaired by Mike Cohen and Christina Michalek (ISMP).
Click on the titles to access the content

IMSN Neuromuscular Blocker SIG Charter


• IMSN Neuromuscular Blocker Safety Interest Group Charter Read on…

IMSN Neuromuscular Blocker SIG Members


• IMSN Neuromuscular Blocker SIG Members List Read on…

April 12, 2023 Neuromuscular Blocker SIG meeting

  • Minutes
    taken by Tyler Nichols, ISMP International Medication Safety Management Fellow

May 31, 2023 Neuromuscular Blocker SIG meeting

Agenda

  • Welcome
  • Introductions (new members)
  • Approval of Charter
  • Country Presentations
    • Canada
      ISMP Canada update
      Sylvia Hyland
    • ISMP US
      Lessons Learned about Human Fallibility, System Design, and Justice in the Aftermath of a Fatal Medication Error: Opportunities for Improvement
      Mike Cohen
  • Next Steps

December 19, 2023 Neuromuscular Blocker SIG meeting

  • Minutes
  • Saudi FDA
    Neuromuscular Blockers: Safety Measures and Labeling Requirements
    Ghadeer M. Banasser

January 10, 2024 Neuromuscular Blocker SIG meeting

  • Minutes
  • France
    Neuromuscular blockers and medication errors : A 10-year pharmacovigilance review
    Marie-Blanche Valnet Rabier for the French PV network
  • France (continued)
    Neuromuscular blockers errors in France
    Étienne Schmitt
  • Abu Dhabi Department of Health
    Neuromuscular Blocker (NMB) Gaps and Solutions
    Dr. Nahed Ali AlRaeesi

January 18, 2024 Neuromuscular Blocker SIG meeting

  • Minutes
  • Canada
    Update from Health Canada
    Kristy Shortall-Cain
  • Colombia - ACQFH (Colombian Society of Hospital Pharmacists)
    Medication Safety Use of NMBs in Colombia:
    The view of the ACQFH medication safety use chapter
    Claudia Pulido

February 7, 2024 Neuromuscular Blocker SIG meeting

  • Minutes
  • Spain
    Neuromuscular Blocking Agent Safety: ISMP-Spain Update
    María José Otero
  • Ireland
    Neuromuscular Blocking Agent Safety: Irish Medication Safety Network Update
    Geraldine Creaton